ESMO 2024
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
ESMO 2024
Sep 17, 2024, 21:57 |
Opinion
Emir Sokolović on the impact of social media interventions in healthcare
Emir Sokolović, Medical Oncology Resident at Clinical center University of Sarajevo, shared on LinkedIn: "An…
Sep 17, 2024, 19:54 |
Insight
Rasha Aboelhassan: Great statement in ESMO24
Rasha Aboelhassan shared on LinkedIn: “Patricia Mucci Lorusso. Great statement in ESMO24. Improve patient care…
Sep 17, 2024, 15:18 |
Blog
Arevik Stepanyan: National Center of Oncology of Armenia team is at ESMO 2024
Arevik Stepanyan, Head of the Cancer Registry Department at the National Center of Oncology in Armenia,…
Sep 17, 2024, 10:06 |
Insight
Sumanta K. Pal: Important analysis of SWOG 1500 published just ahead of ESMO24
Sumanta K. Pal shared a post on X: "Huge congrats to Pedro C Barata, who drove…
Sep 17, 2024, 00:58 |
Blog
David Dellamonica: Focus on tangible actions to redefine cancer care ahead of ESMO 2024
David Dellamonica shared a post by Greg Rossi, Senior Vice President of Oncology Europe and Canada…
Sep 16, 2024, 15:00 |
Insight
Insights from ESMO24 Day 3
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 15, 2024, 15:20 |
Insight
Novel ADC AZD8205 demonstrates manageable safety profile and preliminary efficacy in first-in-human trial
The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar…
Sep 15, 2024, 15:01 |
Insight
MD Anderson Research Highlights Special Edition: ESMO 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent…
Sep 14, 2024, 17:15 |
Societies
45 Posts not to miss from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 10, 2024, 05:08 |
Blog
Tanja Obradovic: Two practice-changing trials of Keytruda within Presidential Symposium of ESMO24
Tanja Obradovic shared on LinkedIn: "ESMO 2024 will have two practice-changing trials of Keytruda (Pembrolizumab)…
Aug 31, 2024, 18:14 |
Blog
Raffaele Giusti: Time Toxicity of Cancer Treatment - Discussion at ESMO 2024
Raffaele Giusti, Medical director at Azienda Ospedaliera Sant'Andrea, shared a post on LinkedIn: "Time Toxicity…
Aug 26, 2024, 21:42 |
Blog
Tanja Obradovic: Interesting update at ESMO 2024 on cancer-induced cachexia as PhII trial of ponsegromab
Tanja Obradovic posted on LinkedIn: “Interesting update will come at ESMO 2024 on possible option…
Aug 15, 2024, 16:57 |
Blog
Shushan Hovsepyan: Must-Attend Educational Sessions at ESMO 2024
Shushan Hovsepyan shared on LinkedIn: "Must-Attend Educational Sessions at ESMO 2024. Get ready for ESMO…
Aug 1, 2024, 16:17 |
Blog
Gevorg Tamamyan: OncoDaily Party Barcelona during the ESMO 2024
Gevorg Tamamyan shared a post on LinkedIn: "Who is coming to ESMO 2024? OncoDaily Party…
Aug 1, 2024, 09:36 |
Insight
List of sessions not to be missed in sarcoma at ESMO 2024 by Shushan Hovsepyan
Shushan Hovsepyan shared on LinkedIn: "The ESMO 2024 author's list is now available and this is…
Jul 30, 2024, 02:16 |
Blog
Myriam Chalabi: Abstract titles for ESMO24 are now online!
Myriam Chalabi shared on X: ”Abstract titles for ESMO24 now online! Full NICHE-3 cohort (59…
Jul 29, 2024, 09:41 |
Blog
All titles and authors of regular abstracts are now online for ESMO 2024
ESMO - European Society for Medical Oncology shared on LinkedIn: "ESMO 24: All titles and…
Jul 24, 2024, 01:00 |
Blog
Yige Bao: Our data from the high-risk UTUC nephron-sparing trial has been accepted at ESMO 2024
Yige Bao, Oncological Urologist and Microbiome researcher in West China Hospital, shared a post on X:…
Jul 13, 2024, 13:27 |
Blog
Jehad Yasin: Two of our abstracts have been accepted for presentation at ESMO Congress 2024
Jehad Yasin, Member of the American Physician Scientists Association (APSA) and ESMO, shared a post…
May 18, 2024, 08:38 |
Opinion
New Insights to Tackle Sexual Impairment in BC - ESMO
The European Society for Medical Oncology (ESMO) shared on X: “ESMO Breast 24: Two studies on…
May 18, 2024, 08:31 |
Opinion
Guillermo Villacampa: Marleen Kok presents the ESMO Breast 24 key message in translation research
Paolo Tarantino shared the following post by Guillermo Villacampa, Biostatistician in the Oncology Data Science…
All:
21
Posts:
1 - 100
43 Posts Not To Miss From ESMO24 Day 2
45 Posts not to miss from ESMO24 Day 1
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube